{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:34Z","timestamp":1777870414617,"version":"3.51.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40620-014-0126-4","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T11:46:11Z","timestamp":1407239171000},"page":"571-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Homocysteine, cysteine, folate and vitamin B12 status in type 2 diabetic patients with chronic kidney disease"],"prefix":"10.1093","volume":"28","author":[{"given":"Anna","family":"Pastore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Noce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Di Giovamberardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Call\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Zenobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarita","family":"Dess\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Di Daniele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,8,6]]},"reference":[{"key":"126_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.71","volume":"36","author":"KT Williams","year":"2010","unstructured":"Williams KT, Schalinske KL (2010) Homocysteine metabolism and its relation to health and disease. BioFactors 36:19\u201324","journal-title":"BioFactors"},{"key":"126_CR2","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1515\/cclm-2012-0372","volume":"50","author":"G Lippi","year":"2012","unstructured":"Lippi G, Plebani M (2012) Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? Clin Chem Lab Med 50:2075\u20132080","journal-title":"Clin Chem Lab Med"},{"key":"126_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1262-3636(07)70176-3","volume":"31","author":"A Rudy","year":"2005","unstructured":"Rudy A, Kowalska I, Straczkowski M, Kinalska I (2005) Homocysteine concentrations and vascular complications in patients with type 2 diabetes. Diabetes Metab 31:112\u2013117","journal-title":"Diabetes Metab"},{"key":"126_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5414\/CNP60375","volume":"60","author":"SK Austen","year":"2003","unstructured":"Austen SK, Coombes JS, Fassett RG (2003) Homocysteine-lowering therapy in renal disease. Clin Nephrol 60:375\u2013385","journal-title":"Clin Nephrol"},{"key":"126_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0026-0495(99)90062-8","volume":"48","author":"J Dierkes","year":"1999","unstructured":"Dierkes J, Domrose U, Ambrosch A et al (1999) Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end stage renal disease. Metabolism 48:631\u2013635","journal-title":"Metabolism"},{"key":"126_CR6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","volume":"298","author":"RL Jamison","year":"2007","unstructured":"Jamison RL, Hartigan P, Kaufman JS et al (2007) Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298:1163\u20131170","journal-title":"JAMA"},{"key":"126_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1373\/clinchem.2005.056119","volume":"52","author":"A Pastore","year":"2006","unstructured":"Pastore A, De Angelis S, Casciani S et al (2006) Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes. Clin Chem 52:145\u2013148","journal-title":"Clin Chem"},{"key":"126_CR8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.numecd.2012.07.002","volume":"23","author":"Z Rafeq","year":"2013","unstructured":"Rafeq Z, Roh JD, Guarino P, Kaufman J, Joseph J (2013) Adverse myocardial effects of B-vitamin therapy in subjects with chronic kidney disease and hyperhomocysteinaemia. Nutr Metab Cardiovasc Dis 23:836\u2013842","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"126_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"126_CR10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5001\/omj.2012.23","volume":"27","author":"WA Mula-Abed","year":"2012","unstructured":"Mula-Abed WA, Al Rasadi K, Al-Riyami D (2012) Estimated glomerular filtration rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice. Oman Med J 27:108\u2013113","journal-title":"Oman Med J"},{"key":"126_CR11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/clinchem\/44.4.825","volume":"44","author":"A Pastore","year":"1998","unstructured":"Pastore A, Massoud R, Motti C et al (1998) Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Clin Chem 44:825\u2013832","journal-title":"Clin Chem"},{"key":"126_CR12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9149(03)00822-1","volume":"92","author":"CU Chae","year":"2003","unstructured":"Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC (2003) Mild renal insufficiency and risk of congestive heart failure in men and women\u00a0\u226570\u00a0years of age. Am J Cardiol 92:682\u2013686","journal-title":"Am J Cardiol"},{"key":"126_CR13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCHEARTFAILURE.109.899070","volume":"4","author":"R Dhingra","year":"2011","unstructured":"Dhingra R, Gaziano JM, Djousse L (2011) Chronic kidney disease and the risk of heart failure in men. Circ Heart Fail 4:138\u2013144","journal-title":"Circ Heart Fail"},{"key":"126_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1997.359","volume":"52","author":"AB Guttormsen","year":"1997","unstructured":"Guttormsen AB, Ueland PM, Svarstad E, Refsum H (1997) Kinetic basis of hyperhomocyteinemia in patients with chronic renal failure. Kidney Int 52:495\u2013502","journal-title":"Kidney Int"},{"key":"126_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","volume":"66","author":"ME Francis","year":"2004","unstructured":"Francis ME, Eggers PW, Hostetter TH, Briggs JP (2004) Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 66:303\u2013312","journal-title":"Kidney Int"},{"key":"126_CR16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1515\/CCLM.2006.245","volume":"44","author":"N Aksoy","year":"2006","unstructured":"Aksoy N, Aksoy M, Cakmak M et al (2006) Increased homocysteine in heart failure: a result of renal impairment? Clin Chem Lab Med 44:1324\u20131329","journal-title":"Clin Chem Lab Med"},{"key":"126_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinbiochem.2006.11.010","volume":"40","author":"YH Lin","year":"2007","unstructured":"Lin YH, Pao KY, Wu VC et al (2007) The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine. Clin Biochem 40:230\u2013234","journal-title":"Clin Biochem"},{"key":"126_CR18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/1471-2164-14-867","volume":"14","author":"T Huang","year":"2013","unstructured":"Huang T, Ren J, Huang J, Li D (2013) Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach. BMC Genom 14:867","journal-title":"BMC Genom"},{"key":"126_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cca.2014.02.007","volume":"431","author":"S Mao","year":"2014","unstructured":"Mao S, Xiang W, Huang S, Zhang A (2014) Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus. Clin Chim Acta 431:206\u2013210","journal-title":"Clin Chim Acta"},{"key":"126_CR20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc10-1006","volume":"34","author":"RV Sekhar","year":"2011","unstructured":"Sekhar RV, McKay SV, Patel SG et al (2011) Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 34:162\u2013167","journal-title":"Diabetes Care"},{"key":"126_CR21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuint.2005.03.001","volume":"46","author":"D Hayes","year":"2005","unstructured":"Hayes D, Wiessner M, Rauen T, McBean GJ (2005) Transport of l-(14C)cystine and l-(14C)cysteine by subtypes of high affinity glutamate transporters over-expressed in HEK cells. Neurochem Int 46:585\u2013594","journal-title":"Neurochem Int"},{"key":"126_CR22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/S0007114511007033","volume":"108","author":"Y Pan","year":"2012","unstructured":"Pan Y, Guo LL, Cai LL et al (2012) Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials. Br J Nutr 108:400\u2013407","journal-title":"Br J Nutr"},{"key":"126_CR23","doi-asserted-by":"crossref","first-page":"e26747","DOI":"10.1371\/journal.pone.0026747","volume":"6","author":"A Satyanarayana","year":"2011","unstructured":"Satyanarayana A, Balakrishna N, Pitla S et al (2011) Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLOS One 6:e26747","journal-title":"PLOS One"},{"key":"126_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/nu2030299","volume":"2","author":"F O\u2019Leary","year":"2010","unstructured":"O\u2019Leary F, Samman S (2010) Vitamin B12 in health and disease. Nutrients 2:299\u2013316","journal-title":"Nutrients"},{"key":"126_CR25","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.2009.1622","volume":"302","author":"M Ebbing","year":"2009","unstructured":"Ebbing M, B\u00f8naa KH, Nygard O et al (2009) Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302:2119\u20132126","journal-title":"JAMA"},{"key":"126_CR26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","volume":"303","author":"AA House","year":"2010","unstructured":"House AA, Eliasziw M, Cattran DC et al (2010) Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303:1603\u20131609","journal-title":"JAMA"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0126-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0126-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:45Z","timestamp":1777564665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/5\/571\/8372175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,6]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0126-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,6]]}}}